Literature DB >> 23737545

Effects of smoking, depression, and anxiety on mortality in COPD patients: a prospective study.

Peian Lou1, Peipei Chen, Pan Zhang, Jiaxi Yu, Yong Wang, Na Chen, Lei Zhang, Hongmin Wu, Jing Zhao.   

Abstract

BACKGROUND: Smoking, depression, and anxiety increase the risk of death in patients with COPD, but the combined effect of these factors is unknown. We assessed the interactive effects of smoking, depression, and anxiety on mortality in patients with COPD.
METHODS: We collected and analyzed data from 7,787 subjects with COPD, in 14 rural communities, from May 2008 to May 2012, and used logistic regression to evaluate the interactions and relative excess risk due to interaction (RERI). We applied the attributable proportion of interaction and the synergy index to evaluate the additive interactions of the factors.
RESULTS: In our COPD subjects the interaction of current smoking and depression symptoms increased the death risk by 3.8-fold (odds ratio 3.78, 95% CI 2.51-5.05), with significant biological interactions (RERI 1.74, 95% CI 0.51-2.99, attributable proportion 0.48, 95% CI 0.13-0.85, synergy index 2.98, 95% CI 1.44-4.56). The biological interactions increased with increasing years or pack-years of smoking: for subjects with ≥ 30 years of smoking: RERI 1.80, 95% CI 1.05-2.75, attributable proportion 0.48, 95% CI 0.15-0.82, synergy index 2.85, 95% CI 1.75-3.96; for subjects with ≥ 40 pack-years of smoking: RERI 3.11, 95% CI 1.54-4.71, attributable proportion 0.60, 95% CI 0.31-0.91, synergy index 4.00, 95% CI 2.84-5.26. Similarly, the combined effect of current smoking and anxiety symptoms increased the death risk by 4.3-fold (odds ratio 4.27, 95% CI 95% CI 2.96-5.59), with significant biological interactions (RERI 1.51, 95% CI 0.31-2.74, attributable proportion 0.46, 95% CI 0.11-0.87, synergy index 2.89, 95% CI 1.31-4.51). The biological interactions also increased with increasing years or pack-years of smoking: for subjects with ≥ 30 years of smoking: RERI 1.41, 95% CI 0.45-2.43, attributable proportion 0.45, 95% CI 0.12-0.81, synergy index 2.88, 95% CI 1.24-5.98; for subjects with ≥ 40 pack-years of smoking: RERI 3.15, 95% CI 2.07-4.61, attributable proportion 0.55, 95% CI 0.21-0.94, synergy index 3.00, 95% CI 1.45-4.75.
CONCLUSIONS: Smoking, depression, and anxiety are associated with higher risk of death in patients with COPD. The risk of death, depression, and anxiety increases with increasing duration of smoking (years) and cigarette pack-years. Chinese Clinical Trials Registration ChiCTR-TRC-12001958.

Entities:  

Keywords:  COPD; anxiety; death; depression; interaction; smoking

Mesh:

Year:  2013        PMID: 23737545     DOI: 10.4187/respcare.02487

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  12 in total

1.  Depression treatment patterns among adults with chronic obstructive pulmonary disease and depression.

Authors:  Arijita Deb; Usha Sambamoorthi
Journal:  Curr Med Res Opin       Date:  2016-11-11       Impact factor: 2.580

Review 2.  Pharmacological treatment of depression in older patients with chronic obstructive pulmonary disease: impact on the course of the disease and health outcomes.

Authors:  A M Yohannes; G S Alexopoulos
Journal:  Drugs Aging       Date:  2014-07       Impact factor: 3.923

3.  Ethnic Inequalities in COPD Outcomes: a Register-Based Study in Copenhagen, Denmark.

Authors:  Yusun Hu; Lourdes Cantarero-Arévalo; Anne Frølich; Ramune Jacobsen
Journal:  J Racial Ethn Health Disparities       Date:  2016-12-15

4.  Association of Psychological Disorders With 30-Day Readmission Rates in Patients With COPD.

Authors:  Gurinder Singh; Wei Zhang; Yong-Fang Kuo; Gulshan Sharma
Journal:  Chest       Date:  2016-01-12       Impact factor: 9.410

5.  Depressive symptoms among patients with COPD according to smoking status: a Danish nationwide case-control study of 21 184 patients.

Authors:  Jakob Hedemark Vestergaard; Pradeesh Sivapalan; Rikke Sørensen; Josefin Eklöf; Imane Achir Alispahic; Anna von Bülow; Niels Seersholm; Jens-Ulrik Stæhr Jensen
Journal:  ERJ Open Res       Date:  2020-11-30

6.  Frequent Exacerbator: The Phenotype at Risk of Depressive Symptoms in Geriatric COPD Patients.

Authors:  Hoi Nam Tse; Cee Zhung Steven Tseng; King Ying Wong; Lai Yun Ng; Tin Lok Lai; Kwok Sang Yee
Journal:  Lung       Date:  2016-05-02       Impact factor: 2.584

Review 7.  Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Authors:  Nirupama Putcha; M Bradley Drummond; Robert A Wise; Nadia N Hansel
Journal:  Semin Respir Crit Care Med       Date:  2015-08-03       Impact factor: 3.119

8.  Sleep Deprivation and Recovery Sleep Prior to a Noxious Inflammatory Insult Influence Characteristics and Duration of Pain.

Authors:  Giancarlo Vanini
Journal:  Sleep       Date:  2016-01-01       Impact factor: 5.849

9.  Fate or coincidence: do COPD and major depression share genetic risk factors?

Authors:  Victoria L Martucci; Bradley Richmond; Lea K Davis; Timothy S Blackwell; Nancy J Cox; David Samuels; Digna Velez Edwards; Melinda C Aldrich
Journal:  Hum Mol Genet       Date:  2021-05-12       Impact factor: 6.150

Review 10.  Overview of the prevalence, impact, and management of depression and anxiety in chronic obstructive pulmonary disease.

Authors:  Maria Panagioti; Charlotte Scott; Amy Blakemore; Peter A Coventry
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.